Prospective Observational Study to Assess Effectiveness and Safety of Intravenous Ferric Carboxymaltose 1000 mg in Patients of Chronic Heart Failure with Iron DeficiEncy - PRIDE-HF Study. (2023). Cardiology and Cardiovascular Medicine, 7(6), 349-354. https://fortunejournals.org/ojs/index.php/ccm/article/view/16439